3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.75
-0.70 (-1.77%)
Mar 4, 2026, 10:35 AM CST
Market Cap3.07B -37.7%
Revenue (ttm)324.87M +489.1%
Net Income133.88M
EPS1.71
Shares Out77.84M
PE Ratio23.10
Forward PEn/a
Dividend0.53 (1.31%)
Ex-Dividend Daten/a
Volume4,209
Average Volume177,232
Open39.15
Previous Close39.45
Day's Range38.50 - 39.45
52-Week Range37.55 - 67.90
Beta0.19
RSI24.83
Earnings DateMar 23, 2026

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements